These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 15913581

  • 1. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, Ector H, Heidbüchel H.
    Cardiovasc Res; 2005 Sep 01; 67(4):655-66. PubMed ID: 15913581
    [Abstract] [Full Text] [Related]

  • 2. Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.
    Qian Y, Meng J, Tang H, Yang G, Deng Y, Wei D, Xiang B, Xiao X.
    Europace; 2010 Mar 01; 12(3):371-7. PubMed ID: 20106797
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
    Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T, Yoshizumi M, Chayama K.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):818-25. PubMed ID: 14998623
    [Abstract] [Full Text] [Related]

  • 4. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
    Wang W, Wu PS, Yang XL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 03; 30(5):1160-2. PubMed ID: 20501421
    [Abstract] [Full Text] [Related]

  • 5. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.
    Gramley F, Lorenzen J, Plisiene J, Rakauskas M, Benetis R, Schmid M, Autschbach R, Knackstedt C, Schimpf T, Mischke K, Gressner A, Hanrath P, Kelm M, Schauerte P.
    J Cardiovasc Electrophysiol; 2007 Sep 03; 18(10):1076-82. PubMed ID: 17655664
    [Abstract] [Full Text] [Related]

  • 6. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ, Spinale FG, Gold MR.
    Am J Cardiol; 2006 Feb 15; 97(4):532-7. PubMed ID: 16461051
    [Abstract] [Full Text] [Related]

  • 7. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
    Zhu H, Zhang W, Guo CH, Zhang G, Zhang WD, Zhong M, Yang GR, Ge ZM, Zhang Y.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 05; 85(1):45-8. PubMed ID: 15808077
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D, Xu CX, Zhang JC, Chen L, Lin YZ, Lin LF, Hu XZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb 05; 33(2):137-42. PubMed ID: 15924808
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL, Huang SK, Lin JL, Lai LP, Lai SC, Liu CW, Chen WC, Wen CH, Lin CS.
    J Mol Cell Cardiol; 2008 Dec 05; 45(6):742-53. PubMed ID: 18692064
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
    González AA, Segura AM, Horiba K, Qian S, Yu ZX, Stetler-Stevenson W, Willerson JT, McAllister HA, Ferrans VJ.
    Hum Pathol; 2002 Dec 05; 33(12):1158-64. PubMed ID: 12514782
    [Abstract] [Full Text] [Related]

  • 12. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G, Sack U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J.
    Tuberculosis (Edinb); 2001 Dec 05; 81(3):203-9. PubMed ID: 11466032
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
    Zhang W, Zhong M, Yang GR, Li JP, Guo C, Wang Z, Zhang Y.
    Cardiovasc Pathol; 2008 Dec 05; 17(6):399-409. PubMed ID: 18706834
    [Abstract] [Full Text] [Related]

  • 14. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K, Ikebuchi M, Kanaoka Y, Ohgi S, Ueta E, Nanba E, Ito H.
    Int Angiol; 2003 Sep 05; 22(3):229-38. PubMed ID: 14612849
    [Abstract] [Full Text] [Related]

  • 15. Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model.
    Anné W, Willems R, Holemans P, Beckers F, Roskams T, Lenaerts I, Ector H, Heidbüchel H.
    J Mol Cell Cardiol; 2007 Aug 05; 43(2):148-58. PubMed ID: 17597147
    [Abstract] [Full Text] [Related]

  • 16. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
    Ke D, Xu CX, Lin YZ, Zhang JC, Chen L, Lin LF, Hu XZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May 05; 33(5):459-63. PubMed ID: 15932710
    [Abstract] [Full Text] [Related]

  • 17. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR, de Araújo VC, Canavez F, Furuse C, Leite KR, de Araújo NS.
    Arch Oral Biol; 2007 Jun 05; 52(6):585-90. PubMed ID: 17181997
    [Abstract] [Full Text] [Related]

  • 18. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
    Masumoto K, de Rooij JD, Suita S, Rottier R, Tibboel D, de Krijger RR.
    Histopathology; 2006 Apr 05; 48(5):588-95. PubMed ID: 16623785
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL, Catanzaro DF, Supino PG, Gupta A, Carter J, Herrold EM, Dumlao TF, Borer JS.
    Cardiology; 2009 Apr 05; 113(3):161-8. PubMed ID: 19129699
    [Abstract] [Full Text] [Related]

  • 20. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
    Kallergis EM, Manios EG, Kanoupakis EM, Mavrakis HE, Arfanakis DA, Maliaraki NE, Lathourakis CE, Chlouverakis GI, Vardas PE.
    J Am Coll Cardiol; 2008 Jul 15; 52(3):211-5. PubMed ID: 18617070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.